Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
In this section, we usually try to help investors determine whether Umatrin Holding is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Umatrin Holding has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.
Show me the analysis anyway
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Umatrin Holding. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
Umatrin Holding's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Umatrin Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Specialty Retail industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare Umatrin Holding's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare Umatrin Holding's earnings growth to the United States of America market average as no estimate data is available.
Unable to compare Umatrin Holding's revenue growth to the United States of America market average as no estimate data is available.
Unable to determine if Umatrin Holding is high growth as no earnings estimate data is available.
Unable to determine if Umatrin Holding is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Umatrin Holding's filings and announcements here.
Umatrin Holding's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Dato Sri Hin Chai Eu, also known as Warren, is a Founder of Umatrin Holding Limited and has been its Chairman, Chief Executive Officer, President and Chief Financial Officer since January 2, 2017 and its Executive Director since August 12, 2014. He served as Vice President of Umatrin Holding Limited from January 6, 2016 to January 2, 2017. He served as the Chief Executive Officer and President of Umatrin since March 31, 2015. He served as a Director of Umatrin since March 31, 2015. He was awarded Sri Sultan Ahmad Shah Pahang (S.S.A.P.) from the Sultan of Pahang that carry the title Dato' Sri in year 2014. Prior to that, he was awarded Darjah Indera Mahkota Pahang (D.I.M.P.) from the Sultan of Pahang in year 2013 that carry the title Dato'. He is a successful business tutor and entrepreneur. He is also philanthropist, where he has contributed to charities like schools, nursing home and orphanage. He holds a Philosophy of Doctorate (Ph.D.) in Finance from the Golden State University in the United States of America (USA).
Warren's compensation has increased whilst company is loss making.
Warren's remuneration is lower than average for companies of similar size in United States of America.
Legal Advisor & Director
VP & Director
Chief Technology Officer
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The average tenure for the Umatrin Holding board of directors is less than 3 years, this suggests a new board.
Umatrin Holding Limited, together with its subsidiaries, sells beauty, personal care, health, and wellness products in Malaysia. Its products include hydrogen antioxidant water purifiers; hydrogen alkaline water sticks; Unibersih, a herbal essence that is used for the treatment of constipation, pigmentation, overweight, bad breath, unsound sleep, lack of physical strength, indigestion, abdominal swelling, dry and pale skin, poor immune system, etc.; and Soyme for preventing heart diseases and anti-aging effects, enhancing blood circulation, and reducing the body’s cholesterol levels. The company also offers Sophielicous, an anti-aging supplement to enhance the longevity of skin cells; AKERO SECRET anti-aging skin care series that include moisturizing cleansing foams, facial toners, brightening serums, soothing emulsions, and ageless and protective sunscreen creams; Akero beauty serum to neutralize and repair the effects of emotional and environmental stress on the skin; and Resveratrol, a natural antioxidant to reduce blood viscosity, inhibit platelet aggregation and vasodilation, maintain blood flow, and prevent the occurrence and development of various cardiovascular problems. It markets its products to retail-based end-users and dealers through an online platform; and a retail shop. Umatrin Holding Limited is based in New York City, New York.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.